a2 Milk Co. Secures Final China Approval for Infant Formula Transfer

MT Newswires Live
06/22

a2 Milk Co. (ASX:A2M, NZE:ATM) received approval from China's State Administration for Market Regulation to transfer two China-label infant milk formula registrations tied to its Pokeno facility to its a2 brand, according to a Monday filing with the New Zealand bourse.

The company confirmed that the acquisition of the a2 Pokeno facility is now irrevocable, given the receipt of all required regulatory approvals, per the filing.

The board is expected to meet soon to consider a NZ$300 million fully franked special dividend, with timing and details to be released upon formal approval, the filing added.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10